NCT03381261View on ClinicalTrials.gov

(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

August 1, 2023

Study Completion Date

December 1, 2023

Conditions
Migraine
Interventions
DRUG

Botulinum toxin type A

Injection of Botulinum toxin type A in back of head

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03381261 - (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist | Biotech Hunter | Biotech Hunter